Our previous research demonstrated the health benefits of sericin-derived oligopeptides (SDOs) from yellow silk cocoons, particularly their hypoglycemic and antihypertensive properties. This study aims to produce SDOs at a pilot scale, preparing them for large commercial production as a novel food ingredient, and investigates the impact of scale-up on their characteristics and specifications. We compared the productivity of SDOs generated from 25 L and 300 L batches via the hydrolysis of sericin using 5% Neutrase (E/S) at 50 °C for 4 h. The 300 L production scale outperformed the 25 L scale, achieving a hydrolysis degree (DH) of 8.63%, a solid recovery rate of 94.35%, and enhanced inhibitory actions for dipeptidyl peptidase IV (DPP-IV) and angiotensin-converting enzyme (ACE). The characterization of peptides was carried out in ultrafiltered SDOs. Peptides < 3 kDa demonstrated optimal enzyme inhibition and were then fractionated by size exclusion chromatography into nine distinct fractions. Of the nine fractions, F1, F8, and F9 had significant enzyme inhibitory activity. LC-MS/MS analysis revealed 32 unique peptide sequences, with YPDLPYH exhibiting significant dual inhibitory effects on both DPP-IV (IC50 1.35 mM) and ACE (IC50 18.10 μM). The maximum residue limit (MRL) for trace metals, pesticide residues, and microbiological contamination in SDOs complies with food regulations. SDOs exhibited stability at 4, 25, and 45 °C for six months, based on their physical characteristics and biological activity. Considering their investigated characteristics, SDOs could be manufactured at a pilot capacity and used as a functional food component in commercial applications designed to improve metabolic health.
This experiment was conducted to study the effects of initial goat milk pH on changes in some physico-chemical properties of milk during freeze-thaw cycles, and to investigate the possible causes by freeze-thawing for 5 cycles to magnify the changes. Raw goat milk was adjusted to 3 alternative pH levels, which were 1) original milk pH, 2) adjusted to original pH-0.2, and 3) adjusted to original pH+0.2. All the milk samples were packed in plastic bags and kept at -18±2°C for 5 days, then thawed at room temperature at 25°C (1 cycle) and this was repeated for 5 cycles. Milk samples from each treatment and each cycle were analyzed for pH, presence of sediment, viscosity, fat droplet size, particle size distribution, heat stability and changes in mineral content of milk serum. The result showed that the goat milk had an original pH of 6.69 (T6.69) that was adjusted to 6.49 (T6.49) and 6.89 (T6.89). During freeze-thawing all the treatment groups exhibited decreasing pH and increasing sediment, milk viscosity and fat droplet size, with only slight differences between treatments. The important differences were in heat stability, as the T6.49 treatment resulted in a heat stability decrease from 80 mins initially to 46 mins (42.50% decrease) at the 5th cycle, whereas T6.89 treatment only had an 8.89% change in heat stability. Average particle diameter (D3,2), volume distribution (D4,3) and uniform distribution (span) increased with freeze-thaw cycles, which clearly showed in T6.49 and T6.69 cases but not distinctly in T6.89. In conclusion, milk pH affected the quality of milk after freeze-thawing. Adjusting pH to 6.89 before freezing in this study reduced changes of pH, sediment formation, coalescence of protein, and heat stability of thawed goat milk; such adjustment is beneficial for further milk processing in the dairy industry.
17 February 2026 in Food Science of Animal Resources
Bovine blood represents 4% of slaughter weight yet remains largely underutilised despite high protein content. This study scaled enzymatic hydrolysis from laboratory to pilot-scale production while evaluating bovine blood hydrolysate (BBH) as an alternative to commercial yeast hydrolysate (YH) in slow-growing chicken (Korat chickens) nutrition. Pilot-scale Neutrase hydrolysis of 400 kg batches achieved 15.08% degree of hydrolysis and 50.23% protein recovery, exceeding laboratory-scale performance. Comprehensive characterization revealed that BBH contained 59% of peptides within the bioactive 0.4 to 2 kDa range and exhibited 45.09% β-sheet secondary structure. Amino acid profiling demonstrated substantial enrichment in branched-chain amino acids, with leucine reaching 11,131 mg per 100 g representing 426% greater abundance than commercial YH. BBH exhibited superior in vitro antioxidant activities, achieving 335 µg Trolox equivalent per mL in ABTS radical scavenging compared to 271 µg for yeast hydrolysate and 122 µg EDTA equivalent per mL in metal chelating versus 90 µg for yeast hydrolysate. In vivo evaluation with 400 Korat chickens demonstrated that 0.1% BBH supplementation significantly enhanced antioxidant enzyme activities by 13 to 33% across superoxide dismutase, glutathione peroxidase, and catalase while maintaining growth performance equivalent to controls. Meat quality improved through 3.86% cooking loss reduction compared to unsupplemented controls ( p < 0.05). Multivariate analysis confirmed functional equivalence between BBH and commercial YH. Therefore, pilot-scale BBH represents a sustainable technology converting meat industry waste into functional feed ingredients supporting enhanced animal health and product quality.
24 March 2026 in Journal of Agriculture and Food Research